SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...

Quidel Corporation ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market ...

At present, real-time polymerase chain reaction (RT-PCR) assay is considered the gold standard for the diagnosis of SARS-CoV-2 infection. RT-PCR is a nuclear-derived method for detecting the presence ...

South Korean researchers from the Gwangju Institute of Science and Technology (GIST) developed a new fluorescence-based lateral-flow immunoassay (LFI) enhanced with gold nanorod (GNR)-based probes to ...

Traditionally, protein biomarkers or analytes have been measured individually in ELISAs, which can attain a high degree of analytical specificity by testing only a single analyte with a dedicated ...

SAN DIEGO, CA--(Marketwire - Nov 7, 2012) - Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it has ...

Biomarker concentrations are a key determinant measurement in many aspects of the drug discovery and development process. Specific biomarker measurements are key components for discovery, ...

Transmission electron microscopy (TEM) image and fluorescence image of fluorescent magnetic Janus particles (top left), Schematic diagram of N protein detection using antibody-conjugated fluorescent ...

Quidel's recently acquired Triage® system of tests comprises a comprehensive test menu that provides rapid, cost-effective treatment decisions at the point-of-care (POC), offering a diverse ...